Valuation: ResMed, Inc.

Capitalization 29.56B 25.21B 23.12B 21.89B 40.56B 2,829B 40.95B 275B 107B 1,342B 111B 109B 4,663B P/E ratio 2026 *
19.2x
P/E ratio 2027 * 17.3x
Enterprise value 28.65B 24.43B 22.41B 21.21B 39.31B 2,742B 39.69B 267B 104B 1,301B 108B 105B 4,519B EV / Sales 2026 *
5.07x
EV / Sales 2027 * 4.59x
Free-Float
75.61%
Yield 2026 *
1.19%
Yield 2027 * 1.32%
1 day+2.53%
1 week-1.97%
Current month-4.69%
1 month-10.96%
3 months-17.07%
6 months-19.41%
Current year-15.39%
1 week 198.61
Extreme 198.61
211.23
1 month 198.61
Extreme 198.61
232.32
Current year 198.61
Extreme 198.61
277.67
1 year 198.61
Extreme 198.61
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.28
Extreme 56.28
301.34
Manager TitleAgeSince
Chief Executive Officer 53 28/02/2013
Director of Finance/CFO 40 03/05/2026
Compliance Officer - 31/12/2017
Director TitleAgeSince
Director/Board Member 78 31/12/2004
Chairman 53 24/01/2023
Chairman 83 31/05/1989
Change 5d. change 1-year change 3-years change Capi.($)
+2.53%-1.97%-17.71%-12.72% 29.56B
+1.48%-1.60%+6.17%-12.46% 171B
+2.81%-4.32%-23.08%+41.47% 153B
-0.16%-4.79%-17.21%-26.87% 118B
+1.37%-3.36%-47.41%+1.42% 80.41B
+3.32%-3.84%+6.59%-10.60% 45.91B
-0.34%-5.11%-31.21%-38.34% 44.35B
+1.19%+2.76%-3.94%+29.97% 34.57B
+1.29%-3.94%-2.29%-11.44% 31.91B
-1.67%-1.19%-27.39%-45.76% 29.63B
Average +0.73%-3.13%-15.75%-8.53% 73.76B
Weighted average by Cap. +0.79%-3.25%-14.83%-2.82%

Financials

2026 *2027 *
Net sales 5.65B 4.82B 4.42B 4.18B 7.75B 541B 7.83B 52.64B 20.5B 256B 21.2B 20.75B 891B 6.08B 5.18B 4.75B 4.5B 8.34B 582B 8.42B 56.63B 22.05B 276B 22.81B 22.33B 959B
Net income 1.54B 1.32B 1.21B 1.14B 2.12B 148B 2.14B 14.38B 5.6B 70.08B 5.79B 5.67B 244B 1.7B 1.45B 1.33B 1.26B 2.34B 163B 2.36B 15.87B 6.18B 77.36B 6.39B 6.26B 269B
Net Debt -913M -778M -714M -676M -1.25B -87.34B -1.26B -8.5B -3.31B -41.43B -3.42B -3.35B -144B -1.64B -1.4B -1.29B -1.22B -2.26B -157B -2.28B -15.32B -5.97B -74.67B -6.17B -6.04B -259B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
12/05/26 203.79 $ +2.53% 1,368,951
11/05/26 198.76 $ -3.87% 1,805,478
08/05/26 206.76 $ -0.06% 993,580
07/05/26 206.89 $ -1.31% 1,315,641
06/05/26 209.64 $ +0.85% 1,444,862
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
203.79USD
Average target price
270.60USD
Spread / Average Target
+32.78%

Quarterly revenue - Rate of surprise